GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 421.01
-18.99 (-4.32%)
At close: Nov 12, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 35.16 billion as of November 13, 2026. It is the 12,540th most valuable company in the world and the 26th biggest in Egypt. Its market cap has increased by 508.57% in one year.
Market Cap
35.16B
Enterprise Value
36.74B
Revenue
3.62B
Global Rank
Country Rank
#26 Egypt
PE Ratio
181.07
ChartMarket Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 35.16B, an increase of 6,074.41%. That is a compound annual growth rate of 21.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 35.16B | 561.45% |
| Dec 31, 2025 | 5.32B | 76.81% |
| Dec 31, 2024 | 3.01B | 1.27% |
| Dec 31, 2023 | 2.97B | -6.84% |
| Dec 29, 2022 | 3.19B | 23.58% |
| Dec 30, 2021 | 2.58B | 82.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding